Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
1.
Sci Rep ; 9(1): 3958, 2019 03 08.
Article in English | MEDLINE | ID: mdl-30850705

ABSTRACT

Colorectal cancer is frequently diagnosed at an advanced stage due to the absence of early clinical indicators. Hence, the identification of new targeting molecules is crucial for an early detection and development of targeted therapies. This study aimed to identify and characterize novel peptides specific for the colorectal cancer cell line RKO using a phage-displayed peptide library. After four rounds of selection plus a negative step with normal colorectal cells, CCD-841-CoN, there was an obvious phage enrichment that specifically bound to RKO cells. Cell-based enzyme-linked immunosorbent assay (ELISA) was performed to assess the most specific peptides leading to the selection of the peptide sequence CPKSNNGVC. Through fluorescence microscopy and cytometry, the synthetic peptide RKOpep was shown to specifically bind to RKO cells, as well as to other human colorectal cancer cells including Caco-2, HCT 116 and HCT-15, but not to the normal non-cancer cells. Moreover, it was shown that RKOpep specifically targeted human colorectal cancer cell tissues. A bioinformatics analysis suggested that the RKOpep targets the monocarboxylate transporter 1, which has been implicated in colorectal cancer progression and prognosis, proven through gene knockdown approaches and shown by immunocytochemistry co-localization studies. The peptide herein identified can be a potential candidate for targeted therapies for colorectal cancer.


Subject(s)
Colorectal Neoplasms/chemistry , Peptide Library , Peptides/analysis , Caco-2 Cells/chemistry , Cell Line, Tumor/chemistry , Colorectal Neoplasms/diagnosis , DNA, Neoplasm/genetics , Enzyme-Linked Immunosorbent Assay , HCT116 Cells/chemistry , Humans , Peptides/genetics , Sequence Alignment , Sequence Analysis, DNA
2.
Org Lett ; 17(12): 3098-101, 2015 Jun 19.
Article in English | MEDLINE | ID: mdl-26068271

ABSTRACT

Two new heterodimeric sesquiterpenes, sterhirsutins C (1) and D (2), along with eight new sesquiterpenoid derivatives, sterhirsutins E--L (3-10), were isolated from the culture of Stereum hirsutum. The absolute configuration of 1 was assigned by a single-crystal X-ray diffraction experiment. Compounds 1 and 2 possessed an unprecedented chemical skeleton with a 5/5/5/6/9/4 fused ring system. Compound 10 is the first sesquiterpene coupled with a xanthine moiety. Compounds 1-10 showed cytotoxicity against K562 and HCT116 cell lines. Compound 9 induced autophagy in HeLa cells. Compound 5 inhibited the activation of IFNß promoter in Sendai virus infected cells.


Subject(s)
Antineoplastic Agents/chemistry , Basidiomycota/chemistry , Fungi/chemistry , HCT116 Cells/chemistry , Immunosuppressive Agents/chemistry , Immunosuppressive Agents/pharmacology , Interferon-beta/chemistry , Sendai virus/chemistry , Sesquiterpenes/chemistry , Sesquiterpenes/pharmacology , Xanthine/chemistry , Antineoplastic Agents/pharmacology , Crystallography, X-Ray , HCT116 Cells/drug effects , HeLa Cells , Humans , Interferon-beta/pharmacology , K562 Cells , Magnetic Resonance Spectroscopy , Molecular Structure , Sendai virus/drug effects , Tibet
3.
J Org Chem ; 80(13): 6715-27, 2015 Jul 02.
Article in English | MEDLINE | ID: mdl-26036279

ABSTRACT

A new three-component assembly reaction between N-tosylhydrazones, dihalogenated arenes, and boronic acids or boronate esters was developed, producing highly substituted 1,1-diarylethylenes in good yields. The two C-C bonds formed through this coupling have been catalyzed by a single Pd-catalyst in a one-pot fashion. It is noted that the one-pot pinacol boronate cross-coupling reaction generally provides products in high yields, offers an expansive substrate scope, and can address a broad range of aryl, styrene, vinyl, and heterocyclic olefinic targets. The scope of this one-pot coupling has been also extended to the synthesis of the 1,1-diarylethylene skeleton of the natural product ratanhine. The new compounds were evaluated for their cytotoxic activity, and this allowed the identification of compound 4ab that exhibits excellent antiproliferative activity in the nanomolar concentration range against HCT116 cancer cell lines.


Subject(s)
Boron Compounds/chemistry , Cyclopropanes/chemical synthesis , Cyclopropanes/pharmacology , Ethylenes/chemical synthesis , Hydrazones/chemistry , Vinyl Compounds/chemical synthesis , Vinyl Compounds/pharmacology , Catalysis , Cell Line , Cyclopropanes/chemistry , Ethylenes/chemistry , HCT116 Cells/chemistry , HCT116 Cells/drug effects , Humans , Molecular Structure , Palladium/chemistry , Vinyl Compounds/chemistry
4.
Arch Toxicol ; 89(5): 797-805, 2015 May.
Article in English | MEDLINE | ID: mdl-24912782

ABSTRACT

The natural compound 1,8-cineol, also known as eucalyptol, is a major constituent of eucalyptus oil. This epoxy-monoterpene is used as flavor and fragrance in consumer goods as well as medical therapies. Due to its anti-inflammatory properties, 1,8-cineol is also applied to treat upper and lower airway diseases. Despite its widespread use, only little is known about the genotoxicity of 1,8-cineol in mammalian cells. This study investigates the genotoxicity and cytotoxicity of 1,8-cineol in human and hamster cells. First, we observed a significant and concentration-dependent increase in oxidative DNA damage in human colon cancer cells, as detected by the Formamidopyrimidine-DNA glycosylase (Fpg)-modified alkaline comet assay. Pre-treatment of cells with the antioxidant N-acetylcysteine prevented the formation of Fpg-sensitive sites after 1,8-cineol treatment, supporting the notion that 1,8-cineol induces oxidative DNA damage. In the dose range of DNA damage induction, 1,8-cineol did neither reduce the viability of colon cancer cells nor affected their cell cycle distribution, suggesting that cells tolerate 1,8-cineol-induced oxidative DNA damage by engaging DNA repair. To test this hypothesis, hamster cell lines with defects in BRCA2 and Rad51, which are essentials players of homologous recombination (HR)-mediated repair, were treated with 1,8-cineol. The monoterpene induced oxidative DNA damage and subsequent DNA double-strand breaks in the hamster cell lines tested. Intriguingly, we detected a significant concentration-dependent decrease in viability of the HR-defective cells, whereas the corresponding wild-type cell lines with functional HR were not affected. Based on these findings, we conclude that 1,8-cineol is weakly genotoxic, inducing primarily oxidative DNA damage, which is most likely tolerated in DNA repair proficient cells without resulting in cell cycle arrest and cell death. However, cells with deficiency in HR were compromised after 1,8-cineol treatment, suggesting a protective role of HR in response to high doses of 1,8-cineol.


Subject(s)
Cyclohexanols/toxicity , DNA Damage/drug effects , Monoterpenes/toxicity , Animals , Cell Line/chemistry , Comet Assay , Cricetinae , Electrophoresis, Polyacrylamide Gel , Eucalyptol , Eucalyptus , HCT116 Cells/chemistry , HCT116 Cells/drug effects , Humans , Immunoblotting , Oxidative Stress/drug effects , Plant Oils/toxicity , Reactive Oxygen Species/analysis
5.
Org Lett ; 15(10): 2538-41, 2013 May 17.
Article in English | MEDLINE | ID: mdl-23639001

ABSTRACT

Bisindole cladoniamides, nanomolar inhibitors of colon cancer cell line HCT-116, contain a rare, indolotryptoline substructure. In this report, the structures of xenocladoniamides A-E (9-13) are described. Compounds 9-13 are generated from a cladoniamide heterologous production system where O-methyltransferase gene claM3 has been inactivated. The results suggest that O-methylation, installed by enzyme ClaM3, is critical to maintaining the structural integrity of the indolotryptoline scaffold. Xenocladoniamides D and E are modestly cytotoxic against colon cancer cell line HCT-116.


Subject(s)
Carbolines/chemistry , HCT116 Cells/chemistry , Indole Alkaloids/chemistry , Biosynthetic Pathways , Cell Line, Tumor , Humans , Indole Alkaloids/metabolism , Methylation , Molecular Structure
6.
Genes Chromosomes Cancer ; 40(3): 247-60, 2004 Jul.
Article in English | MEDLINE | ID: mdl-15139003

ABSTRACT

Loss of heterozygosity (LOH) on 8p occurs at high frequencies in many tumor types, including colorectal carcinoma (CRC). We previously used microcell-mediated chromosome transfer (MMCT) into the CRC cell line SW620 to map a approximately 7.7-Mb colorectal cancer-suppressor region (CRCSR) at 8p22-23.1. In the current study, we transferred small fragments of this CRCSR into SW620 to refine the region further. Two microcell hybrids containing a 321- to 898-kb region around the D8S552 marker at 8p23.1 showed suppression of soft agar clonicity and tumorigenicity in athymic mice when compared to control cell lines. These data suggest that the putative colorectal tumor-suppressor gene is within this small region. We analyzed two candidate genes within this region: FLJ23749 and KIAA1456. Expression of both genes was detected in normal colonic crypt cells and in mucosa. Quantitative reverse transcriptase polymerase chain reaction showed downregulation of KIAA1456 in 9 of 12 primary colorectal tumors compared to matching normal mucosa, but normal or increased expression of FLJ23749. FLJ23749 was expressed in all CRC cell lines tested; however, KIAA1456 was downregulated in three cell lines, including SW620, and was restored in the suppressed microcell hybrids. 5'aza-2'Deoxycytidine treatment of the downregulated cell lines restored expression of KIAA1456, but bisulfite genomic sequencing did not show a correlation between promoter methylation and expression. Forty percent of the primary tumors showed LOH at this CRCSR locus, and mutation analysis revealed somatic mutations in 1 of 88 primary colorectal tumors for both KIAA1456 and FLJ23749. Despite the rarity of somatic mutations, the expression data suggest that KIAA1456 is still a candidate for the putative 8p colorectal cancer tumor-suppressor gene.


Subject(s)
Chromosome Mapping/methods , Chromosomes, Human, Pair 8/genetics , Colorectal Neoplasms/genetics , Genes, Tumor Suppressor , Animals , Caco-2 Cells/chemistry , Caco-2 Cells/metabolism , Cell Line , Cell Line, Tumor , Colorectal Neoplasms/pathology , CpG Islands/genetics , DNA Methylation , DNA Mutational Analysis/methods , DNA, Neoplasm/genetics , Gene Expression Regulation, Neoplastic/genetics , HCT116 Cells/chemistry , HCT116 Cells/metabolism , HT29 Cells/chemistry , HT29 Cells/metabolism , Humans , Hybrid Cells , Loss of Heterozygosity/genetics , Mice , Phenotype , Promoter Regions, Genetic/genetics , Sarcoma/pathology , Transfection/methods
8.
Mol Cancer ; 3: 3, 2004 Jan 16.
Article in English | MEDLINE | ID: mdl-14728717

ABSTRACT

BACKGROUND: Cellular senescence is a state in which mammalian cells enter into an irreversible growth arrest and altered biological functions. The senescence response in mammalian cells can be elicited by DNA-damaging agents. In the present study we report that the DNA-damaging agent N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) is able to induce senescence in the HCT-116 colon cancer cell line. RESULTS: Cells treated with lower concentrations of MNNG (0-25 microM) for 50 h showed a dose-dependent increase in G2/M phase arrest and apoptosis; however, cells treated with higher concentrations of MNNG (50-100 microM) showed a senescence-like G0/G1 phase arrest which was confirmed by increased expression of beta-galactosidase, a senescence induced marker. The G2/M phase arrest and apoptosis were found to be associated with increased levels of p53 protein, but the senescence-like G0/G1 phase arrest was dissociated with p53 protein levels, since the p53 protein levels decreased in senescence-like arrested cells. We further, determined whether the decreased level of p53 was a transcriptional or a translational phenomenon. The results revealed that the decreased level of p53 protein in senescence-like arrested cells was a transcriptional phenomenon since p53 mRNA levels simultaneously decreased after treatment with higher concentrations of MNNG. We also examined the effect of MNNG treatment on other cell cycle-related proteins such as p21, p27, cyclin B1, Cdc2, c-Myc and max. The expression levels of these proteins were increased in cells treated with lower concentrations of MNNG, which supported the G2/M phase arrest. However, cells treated with higher concentrations of MNNG showed decreased levels of these proteins, and hence, may not play a role in cell cycle arrest. We then examined a possible association of the expression of APC protein and telomeric DNA signals with cellular senescence in MNNG-treated cells. We found that protein and mRNA levels of APC were drastically reduced in cells treated with higher concentrations of MNNG. The loss of APC expression might lead to chromosomal instability as well as microtubular disorganization through its dissociation with tubulin. In fact, the protein level of alpha-tubulin was also drastically decreased in senescence-like arrested cells treated with higher concentrations of MNNG. The levels of telomeric DNA also decreased in cells treated with higher concentrations of MNNG. CONCLUSIONS: These results suggest that in response to DNA alkylation damage the senescence-like arrest of HCT-116 cells was associated with decreased levels of APC protein, microtubular organization, and telomeric DNA.


Subject(s)
Adenomatous Polyposis Coli Protein/metabolism , Aging/drug effects , DNA, Neoplasm/metabolism , HCT116 Cells/metabolism , Methylnitronitrosoguanidine/pharmacology , Microtubules/metabolism , Telomere/metabolism , Apoptosis/drug effects , CDC2 Protein Kinase/metabolism , Cell Cycle/drug effects , Cell Division/drug effects , Cell Line, Tumor , Cyclin B/metabolism , Cyclin B1 , Cyclin-Dependent Kinase Inhibitor p21 , Cyclins/metabolism , Dose-Response Relationship, Drug , G1 Phase/drug effects , G2 Phase/drug effects , HCT116 Cells/chemistry , Humans , Proto-Oncogene Proteins c-myc/metabolism , Resting Phase, Cell Cycle/drug effects , Tumor Suppressor Protein p53/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...